1. Home
  2. MDXH vs PED Comparison

MDXH vs PED Comparison

Compare MDXH & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • PED
  • Stock Information
  • Founded
  • MDXH 2003
  • PED N/A
  • Country
  • MDXH Belgium
  • PED United States
  • Employees
  • MDXH N/A
  • PED N/A
  • Industry
  • MDXH
  • PED Oil & Gas Production
  • Sector
  • MDXH
  • PED Energy
  • Exchange
  • MDXH Nasdaq
  • PED Nasdaq
  • Market Cap
  • MDXH 100.5M
  • PED 87.9M
  • IPO Year
  • MDXH 2021
  • PED N/A
  • Fundamental
  • Price
  • MDXH $1.77
  • PED $0.89
  • Analyst Decision
  • MDXH Strong Buy
  • PED Strong Buy
  • Analyst Count
  • MDXH 2
  • PED 2
  • Target Price
  • MDXH $7.00
  • PED $2.00
  • AVG Volume (30 Days)
  • MDXH 98.8K
  • PED 73.1K
  • Earning Date
  • MDXH 11-06-2024
  • PED 11-26-2024
  • Dividend Yield
  • MDXH N/A
  • PED N/A
  • EPS Growth
  • MDXH N/A
  • PED N/A
  • EPS
  • MDXH N/A
  • PED 0.00
  • Revenue
  • MDXH $84,708,000.00
  • PED $33,999,000.00
  • Revenue This Year
  • MDXH $26.39
  • PED $25.95
  • Revenue Next Year
  • MDXH $18.68
  • PED $21.52
  • P/E Ratio
  • MDXH N/A
  • PED $226.11
  • Revenue Growth
  • MDXH 33.01
  • PED 12.92
  • 52 Week Low
  • MDXH $0.35
  • PED $0.61
  • 52 Week High
  • MDXH $4.64
  • PED $1.10
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 26.20
  • PED 40.97
  • Support Level
  • MDXH $1.62
  • PED $0.89
  • Resistance Level
  • MDXH $2.24
  • PED $0.94
  • Average True Range (ATR)
  • MDXH 0.13
  • PED 0.03
  • MACD
  • MDXH -0.01
  • PED -0.00
  • Stochastic Oscillator
  • MDXH 28.57
  • PED 29.31

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on the acquisition and development of oil and natural gas assets in modern drilling and completion techniques and technologies have yet to be applied. The company focuses on legacy proved properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin) and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: